Catalyst Biosciences (CBIO) Peer Comparison

$17.76

$-0.26 (-1.44%)

As on 27-Aug-2026 16:00EDT

Market cap

$637 Mln

Revenue (TTM)

$42 Mln

P/E Ratio

--

P/B Ratio

3.8

Div. Yield

0 %

Edit

	Catalyst Biosciences (CBIO)	Ascendis Pharma A/S - ADR	Medpace Holdings (MEDP)	Exelixis (EXEL)	Arrowhead Pharmaceuticals (ARWR)
Market cap ($ Mln)	637	16,614	17,326	13,400	12,305
Revenue ($ Mln)	42	1,054	2,782	2,436	670
Net Profit ($ Mln)	-162.98	755.85	491.50	860.62	-319.95
Net Margin (%)	-383.95	71.69	17.67	35.33	-47.79
RoE (%)	-88.99	--	110.09	42.98	-71.14
Price to Earnings	--	19.38	36.49	17.01	--
Price-To-Book	3.79	10.05	39.43	7.27	26.44

Income Statement
Liabilities
Assets
Cashflow
Ratios

Income Statement ($ Mln)

	Catalyst Biosciences (CBIO)	Ascendis Pharma A/S - ADR	Medpace Holdings (MEDP)	Exelixis (EXEL)	Arrowhead Pharmaceuticals (ARWR)
Operating Revenue	42.45	1,054.37	2,782.29	2,435.92	669.50
Cost of Revenue	1.68	103.47	1,982.07	85.67	19.14
Gross Profit	10.84	588.53	760.62	2,236.43	829.45
Operating Expenses	180.35	841.45	216.81	1,378.74	895.93
Operating Profit (EBIT)	-168.47	109.45	583.40	971.51	-226.44
Other Income	0.00	0.00	0.00	0.00	0.00
Profit before Tax	-163.12	101.11	598.92	1,035.47	-252.08
Provision for Tax	2.00	-654.74	107.42	174.84	20.05
Profit after Tax (Net Income)	-162.98	755.85	491.50	860.62	-319.95
Minority Interest	0.00	0.00	0.00	0.00	-47.83
Consolidated Profit	0.00	0.00	0.00	0.00	0.00

Liabilities ($ Mln)

	Catalyst Biosciences (CBIO)	Ascendis Pharma A/S - ADR	Medpace Holdings (MEDP)	Exelixis (EXEL)	Arrowhead Pharmaceuticals (ARWR)
Shareholder's Funds	163.26	1,435.90	433.86	1,843.76	465.53
Minority Interest	0.00	0.00	0.00	0.00	-47.83
Non-Current Liabilities	0.97	384.48	187.89	288.55	1,362.63
Current Liabilities	18.54	464.70	1,435.43	361.93	283.35
Total Liabilities	240.29	1,302.02	1,975.47	2,844.42	1,385.30

Assets ($ Mln)

	Catalyst Biosciences (CBIO)	Ascendis Pharma A/S - ADR	Medpace Holdings (MEDP)	Exelixis (EXEL)	Arrowhead Pharmaceuticals (ARWR)
Non-Current Assets	3.75	895.24	1,006.90	1,243.41	440.60
Current Assets	179.01	1,389.84	1,050.29	1,250.82	1,671.41
Total Assets	240.29	1,302.02	1,975.47	2,844.42	1,385.30
Total Debt*	1.44	449.89	120.10	165.93	864.07
Net Current Assets	160.47	0.00	-385.14	888.90	1,388.07

Cashflow ($ Mln)

	Catalyst Biosciences (CBIO)	Ascendis Pharma A/S - ADR	Medpace Holdings (MEDP)	Exelixis (EXEL)	Arrowhead Pharmaceuticals (ARWR)
Cash From Operating Activities	-71.53	51.77	713.22	884.27	179.55
Cash Flow from Investing Activities	-72.92	-8.15	-31.14	350.44	-129.29
Cash from Financing Activities	322.98	34.89	-860.39	-969.59	74.01
Net Cash Inflow / Outflow	--	--	--	--	--

Ratios

Profitability Ratios

	Catalyst Biosciences (CBIO)	Ascendis Pharma A/S - ADR	Medpace Holdings (MEDP)	Exelixis (EXEL)	Arrowhead Pharmaceuticals (ARWR)
ROCE (%)	-135.84	-30.01	53.56	32.82	-0.17
ROE (%)	-88.99	163.18	110.09	42.98	-71.14
ROA (%)	-86.81	26.53	15.64	29.32	-16.12
EBIT Margin (%)	-384.30	5.73	21.13	31.04	-0.77
Net Margin (%)	-383.95	71.69	17.67	35.33	-47.79
Cash Profit Margin (%)	0.00	0.00	0.00	0.00	0.00

Growth Ratios

	Catalyst Biosciences (CBIO)	Ascendis Pharma A/S - ADR	Medpace Holdings (MEDP)	Exelixis (EXEL)	Arrowhead Pharmaceuticals (ARWR)
Revenue Growth (%)	--	114.85	24.67	9.23	12.22
EBIT Growth (%)	-275.40	136.39	18.70	-3.99	93.17
Net Profit Growth (%)	-152.17	378.76	17.50	42.89	-115.58
EPS Growth (%)	88.89	353.27	26.84	50.42	-73.87
Book Value Growth (%)	-85.19	816.12	164.02	-0.70	-13.57

Valuation Ratios

	Catalyst Biosciences (CBIO)	Ascendis Pharma A/S - ADR	Medpace Holdings (MEDP)	Exelixis (EXEL)	Arrowhead Pharmaceuticals (ARWR)
Price / Earnings	-1.55	-59.76	36.06	15.79	-2,869.63
Price / Book Value	1.18	-80.42	35.44	5.72	10.04
Dividend Yield (%)	--	--	--	--	--
EV/EBITDA	-0.18	-121.54	28.08	12.44	25.04
Market Cap ($ Cr)	--	--	--	--	--

Solvency Ratios

	Catalyst Biosciences (CBIO)	Ascendis Pharma A/S - ADR	Medpace Holdings (MEDP)	Exelixis (EXEL)	Arrowhead Pharmaceuticals (ARWR)
Debt to Equity	0.00	0.00	0.00	0.00	1.77
Short term debt to equity ratio	0.00	0.05	0.00	0.00	0.09
Current Ratio	9.66	2.99	0.73	3.46	5.90
Quick Ratio	9.66	2.32	0.73	3.38	5.90
Interest Coverage	-49.07	1.62	--	--	-1.72

Operating Efficiency Ratios

	Catalyst Biosciences (CBIO)	Ascendis Pharma A/S - ADR	Medpace Holdings (MEDP)	Exelixis (EXEL)	Arrowhead Pharmaceuticals (ARWR)
Debtors to sales (%)	0.00	21.25	15.88	13.74	1.28
Asset Turnover	0.23	0.37	0.89	0.83	0.34
Receivable days	305.44	85.52	50.42	43.48	1.50
Inventory Days	--	1,056.70	--	96.17	--
Payable days	21,967.18	331.01	6.26	147.97	221.81
Cash Conversion Cycle	--	811.21	--	-8.32	--

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

Annual
Quarterly